arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

3M Company

MMM Health Care Medical/Dental Instruments
$168.26
▼ -0.2% Today
as of Sep 4, 16:51 ET
Last 30 days -5.43% Jul 27 → Sep 04
$167.07 $171.56 $176.04 $180.53 $185.02 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$167.87
High
$169.59
Low
$167.55
Volume
$2M
Avg Vol
$3M
Mkt Cap
$90.8B
P/E (TTM)
38.23
Beta
—
52w High
$184.90
52w Low
$139.34
Div Yield
—
Shares Out
$516M

Recent Press Releases & News last 60 days · 21 items

mixed ▲ 2 ● 18 ▼ 1
Sep 1 · 14:53 Zacks neutral
MMM Rides on Strong Safety & Industrial Segment: More Upside Ahead?
Aug 27 · 03:14 Simply Wall St. neutral
What’s Going On With 3M (MMM)?
Aug 26 · 15:08 Simply Wall St. neutral
3M (MMM) Stock May Be 11% Below Fair Value On Cash Flow
▸ Show all 21 press releases & news Free account →

Overview

52-week range
$139
$185
63% of range
Avg surprise (last 2)
+6.8%
Avg reaction (last 2)
+2.2%
50% positive
Latest IV / EM
21%
EM ±0.9% · $168 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.23$1.54$1.85$2.17$2.48 Actual $1.67Actual $2.07Actual $2.48Actual $1.88Est $1.77Actual $2.16Est $2.01Actual $1.55Actual $1.23Actual $1.78 MarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$1.7B$3.4B$5.1B$6.8B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.78 — — — — financials
Tue Mar 31, 2026Mar 2026 $1.23 — — — — financials
Tue Sep 30, 2025Sep 2025 $1.55 — — — — financials
Fri Jul 18, 2025Jun/2025 $2.16 $2.01 +7.5% — -3.7% earnings
Tue Apr 22, 2025Mar/2025 $1.88 $1.77 +6.2% — +8.1% earnings
Mon Sep 30, 2024Sep 2024 $2.48 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.07 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.67 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$6.50B$6.03B—$6.52B$6.34B$5.95B—$6.29B
Cost of revenue$3.82B$3.57B—$3.79B$3.65B$3.48B—$3.65B
Gross profit————————
Operating income$984M$1.40B—$1.45B$1.14B$1.25B—$1.32B
Net income$933M$653M—$834M$723M$1.12B—$1.37B
EPS (diluted)$1.78$1.23—$1.55$1.34$2.04—$2.48

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents————————
Inventory$3.77B$3.69B$3.66B$3.89B$4.08B$3.87B$3.70B$4.04B
Total current assets$14.11B$14.39B$16.39B$16.09B$13.43B$15.66B$15.88B$16.30B
Total assets$34.92B$35.44B$37.73B$37.61B$37.99B$39.95B$39.87B$40.88B
Long-term debt$10.90B$10.91B$10.93B$11.85B$12.48B$12.31B$11.12B$11.32B
Total liabilities$31.92B$32.12B$32.99B$32.94B$33.64B$35.43B$35.97B$36.18B
Total equity$2.95B$3.31B$4.70B$4.63B$4.35B$4.52B$3.84B$4.69B

Implied volatility — last 90 days

21%107%193%279%365% Jun 07 — IV 38% · EM ±3.5%Jun 08 — IV 37% · EM ±3.1%Jun 09 — IV 39% · EM ±2.8%Jun 10 — IV 39% · EM ±2.3%Jun 11 — IV 35% · EM ±1.5%Jun 15 — IV 32% · EM ±2.3%Jun 16 — IV 32% · EM ±1.9%Jun 17 — IV 49% · EM ±2.0%Jun 19 — IV 28% · EM ±3.1%Jun 22 — IV 33% · EM ±2.8%Jun 23 — IV 28% · EM ±2.0%Jun 24 — IV 36% · EM ±2.1%Jun 25 — IV 33% · EM ±1.4%Jun 29 — IV 35% · EM ±7.4%Jun 30 — IV 37% · EM ±7.5%Jul 01 — IV 36% · EM ±7.2%Jul 02 — IV 37% · EM ±7.2%Jul 03 — IV 38% · EM ±7.2%Jul 06 — IV 40% · EM ±7.1%Jul 07 — IV 38% · EM ±6.5%Jul 08 — IV 42% · EM ±7.0%Jul 09 — IV 41% · EM ±6.6%Jul 10 — IV 40% · EM ±6.3%Jul 13 — IV 46% · EM ±6.4%Jul 14 — IV 47% · EM ±6.2%Jul 15 — IV 48% · EM ±6.0%Jul 16 — IV 50% · EM ±5.9%Jul 17 — IV 53% · EM ±5.8%Jul 20 — IV 68% · EM ±5.7%Jul 21 — IV 35% · EM ±2.6%Jul 22 — IV 33% · EM ±2.0%Jul 23 — IV 39% · EM ±1.6%Jul 27 — IV 31% · EM ±2.6%Jul 28 — IV 33% · EM ±2.4%Jul 29 — IV 43% · EM ±2.6%Jul 30 — IV 36% · EM ±1.5%Aug 03 — IV 27% · EM ±2.3%Aug 04 — IV 29% · EM ±2.1%Aug 05 — IV 29% · EM ±1.7%Aug 06 — IV 27% · EM ±1.1%Aug 10 — IV 25% · EM ±2.1%Aug 11 — IV 365% · EM ±26.4%Aug 12 — IV 27% · EM ±1.6%Aug 13 — IV 28% · EM ±1.2%Aug 17 — IV 24% · EM ±2.0%Aug 18 — IV 27% · EM ±2.0%Aug 19 — IV 27% · EM ±1.6%Aug 20 — IV 34% · EM ±1.4%Aug 24 — IV 26% · EM ±2.1%Aug 25 — IV 26% · EM ±1.9%Aug 26 — IV 23% · EM ±1.4%Aug 27 — IV 27% · EM ±1.1%Aug 31 — IV 25% · EM ±2.1%Sep 01 — IV 26% · EM ±1.9%Sep 02 — IV 27% · EM ±1.6%Sep 03 — IV 21% · EM ±0.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in